HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Pepti · Catalog · CagriSema (Cagrilintide + Semaglutide)
GLP-1 / amylin blend · research-use
CagriSema blend OEM supply.
Research-grade cagrilintide + semaglutide co-formulated vials for B2B buyers and private-label brands, shipped with per-component COA.
!
Research use — supplied as research peptides; buyers confirm local compliance
On 2026-04-30 the FDA proposed removing GLP-1 medications from the regulatory bulk-substance framework. Pending finalization, US regulated bulk-substance facilities cannot compound these from bulk substances. Pepti positions GLP-1 compounds for research and private-label brand evaluation worldwide. Read the GLP-1 2026 update →
CagriSemaHPLC ≥ 99%MS confirmed5mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | CagriSema (Cagrilintide + Semaglutide) |
|---|---|
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5mg / 20mg |
| Documentation | Batch-document availability confirmed by product, specification and applicable lot |
| Distribution scope | Research use, worldwide |
| Storage | Lyophilized powder: store at -20°C, protected from light and moisture; typically stable 24+ months. After reconstitution, hold at 2-8°C and use within the validated study window. Ships cold-chain with ice packs. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 5–10 days |
| Production lot | 500–2,000 vials | 14–21 days |
| OEM repeat | 2,000+ vials | 21–28 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
About CagriSema (Cagrilintide + Semaglutide).
CagriSema is a fixed-ratio co-formulation of two distinct peptides: cagrilintide, a long-acting amylin/calcitonin receptor agonist (CAS 1415456-99-3), and semaglutide, a GLP-1 receptor agonist (CAS 910463-68-2). Because the material combines two separate active peptides, the blend carries no single CAS number, molecular formula, or molecular weight; each component is characterized independently by HPLC and mass spectrometry.
Documentation
Batch documentation support for CagriSema (Cagrilintide + Semaglutide) lots.
batch-document availability confirmed by product, specification and applicable lot. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the CagriSema (Cagrilintide + Semaglutide) reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
CagriSema (Cagrilintide + Semaglutide) — frequently asked by B2B buyers.
Is CagriSema supplied as one peptide or a blend?
It ships as a co-formulated blend of two separate peptides, cagrilintide and semaglutide, lyophilized together in a single vial. Because it is a two-API blend, there is no single CAS number or molecular weight; each component is identified and quantified independently on the COA.
What vial sizes, ratios and MOQ are available?
Standard research vials are offered at 5 mg and 20 mg total peptide, with a minimum order of 50 kits (500 vials). The cagrilintide-to-semaglutide ratio can be specified per project; contact us for custom ratios or fill volumes.
What documentation ships with each lot?
For the applicable lot, Pepti confirms whether available documentation includes a Certificate of Analysis reporting HPLC purity and mass-spectrometry (MS) identity for both components, plus appearance, peptide content, and residual water/solvent data. Independent third-party verification is available on request.
Can Pepti private-label or customize the fill?
Yes. As an OEM and private-label manufacturer we support custom vial labeling, box and blister packaging, blend-ratio adjustments, and bulk API supply. Send your artwork and specifications with the RFQ.
What is the compliance status of this material?
It is supplied strictly as a research-use, laboratory reference material for B2B buyers, not for consumer or veterinary use. The branded finished combination is an investigational drug under regulatory review; buyers are responsible for import, labeling, and end-use compliance in their own jurisdiction.
Related compounds
Related research peptides.
COA library search
Search public COAs for this product.
The public COA library is being expanded by product and specification. Use the search link below to check current public records for this item.